|
|
|
|
|
|
|
19.08.26 - 17:54
|
Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers (Bloomberg)
|
|
|
On this episode of Stock Movers:
- Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday.
- Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views.
- Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate. (Source: Bloomberg)...
|
|
|
19.08.26 - 17:24
|
Target Raises Sales Outlook as Turnaround Gains Strength (Bloomberg)
|
|
|
Joe Feldman, senior research analyst and assistant director of research at Telsey, says there is a “strong signal that the turnaround is working” at Target. The retailer lifted its full-year guidance after results outpaced estimates in the second-quarter. (Source: Bloomberg)...
|
|
|
|
|
|
|
19.08.26 - 16:48
|
433 Prozent Gewinn mit Moderna (Der Aktionaer)
|
|
|
Im Aktien-Report „Hot-Stocks EXTREM“ (vom 12.12.2025) hatte ich im Rahmen eines Ausblicks prognostiziert, dass mRNA-Impfstoffe im Jahr 2026 eine überraschende Renaissance erleben könnten. Im Beitrag „Naht bei Moderna eine Kursexplosion?“ (siehe hierzu die Seite 4; damaliger Kurs: 29,63 Dollar) war zu lesen: „Positiv hingegen: 2026 werden Daten aus der dritten Studienphase für ein Präparat gegen Hautkrebs erwartet, welches in Kombination mit Keytruda (von Merck & Co....
|
|
|
|
|
19.08.26 - 16:45
|
Poll: 63 percent say inappropriate for Trump, family to profit from cryptocurrency (The Hill)
|
|
|
Most Americans believe it is inappropriate for President Trump to proft from cyrptocurrency while he is president, according to a new poll. In the Reuters/Ipsos poll, 63 percent of respondents said Trump and his family profiting from cryptocurrency is inappropriate, while 32 percent disagreed and 5 percent did not answer the question. Last month, top......
|
|
|
|
|
|
|
|
|
|
|
19.08.26 - 16:01
|
Infineon-Aktie: Konkurrent mit starken Zahlen, trotzdem hält die Kursmisere an! (Ariva)
|
|
|
Der Halbleiterhersteller Analog Devices hat am Mittwochmittag starke Quartalszahlen vorgelegt. Neuer Schwung für Infineon will trotzdem nicht aufkommen. Infineon-Aktie: Die Rallye-Pause geht weiter Der anhaltende KI-Boom beschert längst nicht mehr nur den Herstellern von GPUs, wie AMD und Nvidia, stark wachsende Geschäfte, sondern auch den Produzenten von analogen Halbleitern. Besonders gefragt sind Produkte für das Temperatur- und ......
|
|
|
|
|
|
|
|
|
|
|
19.08.26 - 15:06
|
Progressive Corp. July Net Profit Down 12% (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Insurer Progressive Corp. (PGR) reported Wednesday that July 2026 net income was $961 million or $1.65 per share, down from $1.09 billion or $1.85 per share in July 2025.Net......
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
